Candel Therapeutics Inc. Soared
Thu, Apr 04, 2024 at 07:22 PM
Candel Therapeutics Inc. (CADL:NASDAQ) jumped higher at $6.4, a gain of 281%. On Thu, Apr 04, 2024, CADL:NASDAQ touched a New 2-Week High of $6.4. The stock got featured on our News Catalysts scanner on Thu, Apr 04, 2024 at 02:13 PM in the 'BIOTECH' category. From Thu, Mar 21, 2024, the stock recorded 66.67% Up Days and 50.00% Green Days
About Candel Therapeutics Inc. (CADL:NASDAQ)
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
Top 10 Gainers:
- Candel Therapeutics Inc. (CADL:NASDAQ), 280.95%
- Allurion Technologies Inc. (ALUR:NYSE), 78.03%
- two Class A (TWOA:NYSE), 71.47%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 71.43%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 50%
- HWH International Inc. (HWH:NASDAQ), 46.5%
- Hub Cyber Security Ltd. (HUBC:NASDAQ), 44.65%
- StoneBridge Acquisition Corporation (APAC:NASDAQ), 43.03%
- Cazoo Group Ltd Class A (CZOO:NYSE), 40.29%